Novetide

About

Novetide manufactures commercially available peptide products, with a robust pipeline of products in development. The companys technology platform is based on several proprietary technologies and expertise in the development and production of peptides through sequence assembly, downstream processing, characterization, and documentation of peptide drug substances. Novetides two FDA-approved production sites have flexible and scalable manufacturing capabilities, with output ranging from grams to tons. Its peptides are currently sold to multinational pharmaceutical companies, start-up companies, and researchers worldwide. Teva Pharmaceuticals has held 50% of Novetide since 2000.

Facts

Acquisitions (1)

Team (1)

News mentions (2)

1. Feb 18, 2018 — www.4-traders.com: Article
2. Jul 24, 2016 — www.aihitdata.com: Article